Search research articles
Contact Us
Filters
Showing results (91-100 of 132) with videos related to
Page
of 14
Sort By:
La Nouvelle Presse Medicale
|
May 17, 1975
[Intravascular hemolysis. Assessment by determination of haptoglobin, hemopexin and orosomucoid]
R Engler, A Wakin, J Pointis, et al.
The Journal of Clinical Investigation
|
September 1, 1977
Pharmacologic and hemodynamic influences on the rate of isovolumic left ventricular relaxation in the normal conscious dog
J S Karliner, M M LeWinter, F Mahler, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
March 1, 1988
Alpha-1-acid glycoprotein concentrations and protein binding of propranolol in Sprague-Dawley and Dark Agouti rat strains treated by phenobarbital
L Chauvelot-Moachon, F Delers, C Poüs, et al.
Autoimmunity
|
January 1, 1992
Anti-RNA polymerase I antibodies in the sera of MRL lupus mice at the initial stages of disease are directed primarily against phosphorylation-dependent epitopes
D A Stetler, D Signorelli, J Neil, et al.
Transactions of the Royal Society of Tropical Medicine and Hygiene
|
January 1, 1985
Malaria, cause of ahaptoglobinaemia in Africans
J F Trape, A Fribourg-Blanc, M F Bosseno, et al.
Experientia
|
February 15, 1974
Orosomucoid, seromucoid and haptoglobin in serum during adjuvant arthritis of the rat
M Sternberg, J Peyroux, R Engler, et al.
Biotechnology Progress
|
June 8, 2002
Enhanced-rate biodegradation of organophosphate neurotoxins by immobilized nongrowing bacteria
Jin-Woo Kim, Evguenia I Rainina, Walter W Mulbry, et al.
Regulatory Toxicology and Pharmacology : RTP
|
August 1, 1991
Evaluation of the carcinogenic potential of pesticides. 3. Aliette
J A Quest, K L Hamernik, R Engler, et al.
The Journal of Nutrition
|
November 1, 1992
Cysteine and glycine supplementation modulate the metabolic response to tumor necrosis factor alpha in rats fed a low protein diet
R F Grimble, A A Jackson, C Persaud, et al.
Blood
|
July 17, 2010
The poor response to imatinib observed in CML patients with low OCT-1 activity is not attributable to lower uptake of imatinib into their CD34+ cells
Jane R Engler, Amity Frede, Verity Saunders, et al.
Page
of 14
Search research articles
Search
Showing results (91-100 of 132) with videos related to
Sort By:
Page
of 14
La Nouvelle Presse Medicale
|
May 17, 1975
[Intravascular hemolysis. Assessment by determination of haptoglobin, hemopexin and orosomucoid]
R Engler, A Wakin, J Pointis, et al.
The Journal of Clinical Investigation
|
September 1, 1977
Pharmacologic and hemodynamic influences on the rate of isovolumic left ventricular relaxation in the normal conscious dog
J S Karliner, M M LeWinter, F Mahler, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
March 1, 1988
Alpha-1-acid glycoprotein concentrations and protein binding of propranolol in Sprague-Dawley and Dark Agouti rat strains treated by phenobarbital
L Chauvelot-Moachon, F Delers, C Poüs, et al.
Autoimmunity
|
January 1, 1992
Anti-RNA polymerase I antibodies in the sera of MRL lupus mice at the initial stages of disease are directed primarily against phosphorylation-dependent epitopes
D A Stetler, D Signorelli, J Neil, et al.
Transactions of the Royal Society of Tropical Medicine and Hygiene
|
January 1, 1985
Malaria, cause of ahaptoglobinaemia in Africans
J F Trape, A Fribourg-Blanc, M F Bosseno, et al.
Experientia
|
February 15, 1974
Orosomucoid, seromucoid and haptoglobin in serum during adjuvant arthritis of the rat
M Sternberg, J Peyroux, R Engler, et al.
Biotechnology Progress
|
June 8, 2002
Enhanced-rate biodegradation of organophosphate neurotoxins by immobilized nongrowing bacteria
Jin-Woo Kim, Evguenia I Rainina, Walter W Mulbry, et al.
Regulatory Toxicology and Pharmacology : RTP
|
August 1, 1991
Evaluation of the carcinogenic potential of pesticides. 3. Aliette
J A Quest, K L Hamernik, R Engler, et al.
The Journal of Nutrition
|
November 1, 1992
Cysteine and glycine supplementation modulate the metabolic response to tumor necrosis factor alpha in rats fed a low protein diet
R F Grimble, A A Jackson, C Persaud, et al.
Blood
|
July 17, 2010
The poor response to imatinib observed in CML patients with low OCT-1 activity is not attributable to lower uptake of imatinib into their CD34+ cells
Jane R Engler, Amity Frede, Verity Saunders, et al.
Page
of 14